Goldman Sachs
HHS icon

Goldman Sachs’s Harte-Hanks HHS Stock Holding History

Goldman Sachs’s Portfolio HHS Stock Details HHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,051
Closed -$51.9K – 6470
2025
Q2 		$51.9K Buy
13,051
+2,841
+28% +$12.7K ﹤0.01% 5911
2025
Q1 		$49K Buy
+10,210
New +$52.1K ﹤0.01% 5881
2022
Q4 		– Sell
-11,333
Closed -$126K – 6110
2022
Q3 		$126K Buy
+11,333
New +$151K ﹤0.01% 5624
2018
Q1 		– Sell
-1,409
Closed -$13K – 6088
2017
Q4 		$13K Sell
1,409
-1
-0.1% -$10 ﹤0.01% 6170
2017
Q3 		$15K Sell
1,410
-7,137
-84% -$65.7K ﹤0.01% 6470
2017
Q2 		$88K Sell
8,547
-2,301
-21% -$29K ﹤0.01% 6174
2017
Q1 		$152K Sell
10,848
-2,631
-20% -$40.1K ﹤0.01% 5867
2016
Q4 		$204K Sell
13,479
-7,919
-37% -$120K ﹤0.01% 5755
2016
Q3 		$347K Sell
21,398
-2,988
-12% -$49.2K ﹤0.01% 5363
2016
Q2 		$388K Buy
24,386
+7,601
+45% +$134K ﹤0.01% 5102
2016
Q1 		$425K Buy
16,785
+2,562
+18% +$78.7K ﹤0.01% 4909
2015
Q4 		$461K Buy
14,223
+4,049
+40% +$152K ﹤0.01% 4993
2015
Q3 		$359K Sell
10,174
-202
-2% -$9.11K ﹤0.01% 5452
2015
Q2 		$618K Sell
10,376
-2,193
-17% -$147K ﹤0.01% 4975
2015
Q1 		$981K Sell
12,569
-3,218
-20% -$249K ﹤0.01% 4502
2014
Q4 		$1.22M Buy
15,787
+3,848
+32% +$252K ﹤0.01% 4356
2014
Q3 		$761K Buy
11,939
+2,715
+29% +$185K ﹤0.01% 4888
2014
Q2 		$663K Sell
9,224
-10
-0.1% -$772 ﹤0.01% 5073
2014
Q1 		$816K Sell
9,234
-13,184
-59% -$1.03M ﹤0.01% 4869
2013
Q4 		$1.75M Sell
22,418
-8,987
-29% -$733K ﹤0.01% 4215
2013
Q3 		$2.77M Buy
31,405
+11,168
+55% +$1.02M ﹤0.01% 3581
2013
Q2 		$1.74M Buy
+20,237
New +$1.68M ﹤0.01% 3853

Other funds holding HHS

William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
WCM
Westerly Capital Management San Francisco, California $542M AUM 48.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Raffles Associates New York $117M AUM 22.1% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Goldman Sachs's HHS Position: Q3 2025 in Review

Goldman Sachs sold out of Harte-Hanks (HHS) in Q3 2025, closing a stake of 13,051 shares — an estimated $51.9K sold.

Goldman Sachs first reported a position in HHS in Q2 2013 and held it in 22 quarters. The position peaked at $2.77M in Q3 2013. 23 funds tracked by Wall St. Rank hold HHS as of Q3 2025.

  • Goldman Sachs reported no remaining Harte-Hanks position as of Q3 2025 after selling out during the quarter.
  • Goldman Sachs sold 13,051 Harte-Hanks shares in Q3 2025, an estimated $51.9K.
  • Goldman Sachs first reported a position in Harte-Hanks in Q2 2013 and held it in 22 quarters.
  • Goldman Sachs's Harte-Hanks position peaked at $2.77M in Q3 2013.
  • 23 funds tracked by Wall St. Rank held Harte-Hanks as of Q3 2025.

Based on Goldman Sachs's 13F filing for Q3 2025, filed 14 Nov 2025.